Rabacfosadine for Relapsed Canine B-Cell Lymphoma: Efficacy and Adverse Event Profiles of 2 Different Doses
Veterinary and Comparative Oncology - United Kingdom
doi 10.1111/vco.12337
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 11, 2017
Authors
Publisher
Wiley